Market Tracker

10/31 5:45pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

During the Trading Day
8.53 +0.06 / +0.71%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.53 +0.001 / +0.01%
 
Volume: 69.4K

Today’s Trading

Previous close8.47
Today’s open8.57
Day’s range8.46 - 8.59
Volume2,132,756
Average volume (3 months)3,216,936
Market cap$1.4B
Dividend yield7.03%
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+32.53%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio5.1
Price/Sales2.66
Price/Book10.44

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.19+1.49%
PTCTPTC Therapeutics Inc+0.14+0.34%
GWPHGW Pharmaceuticals P...+3.29+4.67%
NBIXNeurocrine Bioscienc...+0.08+0.43%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)$0.61
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts